JOEL ROBERTS: Open Payments
NPI 1013649797 · TEMECULA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$342 in 12 payments from 6 companies in 2025. Trend: 2023 $16 · 2024 $157 · 2025 $342
Food & beverage: $342
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 5 | $162 |
| Organon LLC | 2 | $47 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $41 |
| Galderma Laboratories, L.P. | 2 | $39 |
| UCB, Inc. | 1 | $33 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
Products named: DUPIXENT, VTAMA, NEMLUVIO, Bimzelx, Sotyktu.
Industry payments across CA — which companies pay providers there.
